Page 99 - MEMORIA_SEHH-FEHH_2023
P. 99
MEMORIA ANUAL 2023
SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
PETHEMA
FUNDACIÓN ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
Publicaciones en revistas científicas
Internacionales
• Definition and Clinical Significance of the Monoclonal Gammopathy of Undeter-
mined Significance-Like Phenotype in Patients With Monoclonal Gammopathies.
J Clin Oncol. 2023;41(16):3019-31. doi: 10.1200/JCO.22.01916. Epub 2023 Mar 17.
Burgos L, Tamariz-Amador LE, Puig N, Cedena MT, Guerrero C, Jelínek T, Johnson S, Milani P,
Cordón L, Pérez JJ, Lasa M, Termini R, Oriol A, Hernández MT, Palomera L, Martínez-Martínez
R, de la Rubia J, de Arriba F, Ríos R, González ME, Gironella M, Cabañas V, Casanova M, Krs-
nik I, Pérez-Montaña A, González-Calle V, Rodríguez-Otero P, Maisnar V, Hajek R, Van Rhee F,
Jiménez-Zepeda V, Palladini G, Merlini G, Orfao A, de la Cruz J, Martínez-López J, Lahuerta JJ,
Rosiñol L, Bladé J, Mateos MV, San-Miguel JF, Paiva B; PETHEMA/GEM Cooperative Group.
• Prevention and management of adverse events during treatment with bispecific
antibodies and CAR T cells in multiple myeloma: a consensus report of the European
Myeloma Network.
Lancet Oncol. 2023;24(6):e255-e269. doi: 10.1016/S1470-2045(23)00159-6.
Ludwig H, Terpos E, van de Donk N, Mateos MV, Moreau P, Dimopoulos MA, Delforge M,
Rodríguez-Otero P, San-Miguel J, Yong K, Gay F, Einsele H, Mina R, Caers J, Driessen C,
Musto P, Zweegman S, Engelhardt M, Cook G, Weisel K, Broijl A, Beksac M, Bila J, Schjes-
vold F, Cavo M, Hajek R, Touzeau C, Boccadoro M, Sonneveld P.
• Management of multiple myeloma-related renal impairment: recommendations from
the International Myeloma Working Group.
Lancet Oncol. 2023;24(7):e293-e311. doi: 10.1016/S1470-2045(23)00223-1.
Dimopoulos MA, Merlini G, Bridoux F, Leung N, Mikhael J, Harrison SJ, Kastritis E, Gar-
deret L, Gozzetti A, van de Donk NWCJ, Weisel KC, Badros AZ, Beksac M, Hillengass J,
Mohty M, Ho PJ, Ntanasis-Stathopoulos I, Mateos MV, Richardson P, Bladé J, Moreau P,
San-Miguel J, Munshi N, Rajkumar SV, Durie BGM, Ludwig H, Terpos E; International Mye-
loma Working Group.
• More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-
Like Multiple Myeloma.
J Clin Oncol. 2023;41(7):1383-92. doi: 10.1200/JCO.22.01226.
Jelinek T, Bezdekova R, Zihala D, Sevcikova T, Anilkumar Sithara A, Pospisilova L, Sevciko-
va S, Polackova P, Stork M, Knechtova Z, Venglar O, Kapustova V, Popkova T, Muronova L,
Chyra Z, Hrdinka M, Simicek M, Garcés JJ, Puig N, Cedena MT, Jurczyszyn A, Castillo JJ,
Penka M, Radocha J, Mateos MV, San-Miguel JF, Paiva B, Pour L, Rihova L, Hajek R.
99
